| 1 |
35526327 | Bacillus subtilis plays a role in the inhibition of transporter ABCB1 in Caco-2 cells. | 2022 Jul |
1 |
| 2 |
33534133 | Deinduction of P-glycoprotein resulting in delayed viral response during hepatitis C treatment. | 2021 Oct |
2 |
| 3 |
34411648 | ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. | 2021 Dec 30 |
6 |
| 4 |
34653781 | Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis. | 2021 Nov |
6 |
| 5 |
31361500 | Transcriptional and Post-Transcriptional Regulation of Duodenal P-Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine. | 2019 Sep 3 |
2 |
| 6 |
28961159 | In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2. | 2017 Sep 29 |
2 |
| 7 |
29040230 | Serum Concentrations of Paliperidone After Administration of the Long-Acting Injectable Formulation. | 2017 Dec |
1 |
| 8 |
27450623 | Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs. | 2016 Oct |
2 |
| 9 |
26009790 | Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine. | 2015 Aug |
1 |
| 10 |
26421491 | Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. | 2015 Nov |
5 |
| 11 |
26555147 | Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients. | 2015 |
1 |
| 12 |
24406279 | Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response. | 2014 |
1 |
| 13 |
24477677 | Marked differences in the effect of antiepileptic and cytostatic drugs on the functionality of P-glycoprotein in human and rat brain capillary endothelial cell lines. | 2014 Jun |
1 |
| 14 |
24861996 | Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy. | 2014 Aug |
1 |
| 15 |
25495409 | Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. | 2014 |
2 |
| 16 |
23252947 | Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. | 2013 Jan |
3 |
| 17 |
23717663 | Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital. | 2013 |
4 |
| 18 |
24338387 | G2677T polymorphism can predict treatment outcome of Malaysians with complex partial seizures being treated with Carbamazepine. | 2013 Nov 26 |
1 |
| 19 |
21950458 | Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers. | 2012 Mar |
2 |
| 20 |
22188362 | Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. | 2012 Jan |
1 |
| 21 |
21316268 | Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. | 2011 Jun |
2 |
| 22 |
21493161 | Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. | 2011 May |
5 |
| 23 |
21530324 | Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy. | 2011 Sep |
2 |
| 24 |
21692796 | In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein. | 2011 Oct |
5 |
| 25 |
20417680 | Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients. | 2010 Sep |
1 |
| 26 |
19206053 | [Pharmacokinetic problems in clinical practice: role of drug transporters]. | 2009 Feb |
1 |
| 27 |
19934718 | Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine. | 2009 Nov |
1 |
| 28 |
17917461 | Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey. | 2008 |
6 |
| 29 |
17971810 | Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin. | 2008 Jul |
1 |
| 30 |
17376120 | Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition. | 2007 Apr |
3 |
| 31 |
16753003 | ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. | 2006 Jun |
3 |
| 32 |
16842400 | Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements. | 2006 Aug |
4 |
| 33 |
15371980 | Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. | 2004 Sep |
2 |
| 34 |
12954800 | Interaction of antiepileptic drugs with human P-glycoprotein in vitro. | 2003 Oct |
1 |
| 35 |
11318771 | Carbamazepine is not a substrate for P-glycoprotein. | 2001 Apr |
5 |
| 36 |
11733711 | P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. | 2001 Nov 16 |
2 |